SCHEMBL8222885

SCHEMBL8222885

CN(C)Cc1c[nH]c2cc(F)c(F)cc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 4/20 0.65
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KMT2A Q03164 2/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
TSHR P16473 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD17B10 Q99714 1/20 0.54
HTR1A P08908 4/20 0.52
MPO P05164 3/20 0.46
SLC6A4 P31645 2/20 0.44
HTR2A P28223 8/20 0.42
HTR2C P28335 6/20 0.42
HTR2B P41595 4/20 0.42
HTR1D P28221 2/20 0.42
HTR1B P28222 2/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29445177 1.00 GPR84 (0.65) GPR84KDM4EMEN1ALDH1A1KMT2A
SCHEMBL21131303 0.88 GPR84 (0.50) GPR84KDM4EMEN1ALDH1A1KMT2A
SCHEMBL4720689 0.87 KDM4E (0.49) GPR84KDM4EMEN1ALDH1A1KMT2A
SCHEMBL1196112 0.84 HTR1A (0.75) GPR84KDM4EMEN1ALDH1A1KMT2A
SCHEMBL30483734 0.83 HTR1A (0.74) GPR84CYP2D6HTR1AMPOSLC6A4
SCHEMBL4633747 0.83 MPO (0.68) GPR84KDM4EMEN1ALDH1A1KMT2A
SCHEMBL25747532 0.83 HTR1A (0.74) GPR84CYP2D6HTR1AMPOSLC6A4
SCHEMBL24358682 0.79 GPR84 (0.71) GPR84KMT2AHTR1AMPOHTR2A
SCHEMBL1241322 0.79 GPR84 (0.67) GPR84KDM4EMEN1ALDH1A1KMT2A
SCHEMBL3216581 0.79 MPO (0.72) GPR84KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067639-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS University of Florida Research Foundation, Incorporation (US) 2024-02-29 US disclosed
US-20240067639-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS University of Florida Research Foundation, Incorporation (US) 2024-02-29 US disclosed
WO-2008040974-A1 INDOLES FOR USE AS DPP-IV INHIBITORS PEAKDALE MOLECULAR LIMITED (GB) 2008-04-10 WO disclosed
CN-1233630-C N-substituted indole derivative preparation method OCEAN UNIV CHINA (CN) 2005-12-28 CN disclosed
CN-1544419-A N-substituted indole derivative preparation method 中国海洋大学 2004-11-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067639-A1 SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS FUS, SNRPE, RRBP1 GPR84 3306/4885KDM4E 1687/4885MEN1 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.